Med-Chemist : "Quintessential Medicinal Chemistry"
Wednesday, December 8, 2021
FDA Approves Tavneos (avacopan) for the Adjunctive Treatment of ANCA-Associated Vasculitis
›
ChemoCentryx, Inc., (Nasdaq: CCXI), announced the U.S. Food and Drug Administration (FDA) approval of Tavneos (avacopan), an orally a...
Tuesday, December 7, 2021
FDA Approves Livmarli (maralixibat) for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
›
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), announced the U.S. Food and Drug Administration (FDA) approval of Livmarli (maralixibat) o...
Monday, December 6, 2021
FDA Approves Qulipta (atogepant) Oral CGRP Receptor Antagonist for the Preventive Treatment of Migraine
›
In continuation of my update on Qulipta (atogepant), AbbVie (NYSE: ABBV) announced the U.S. Food and Drug Administration (FDA) appro...
Saturday, December 4, 2021
FDA Approves Opzelura (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD)
›
In continuation of my update on Opzelura (ruxolitinib) , Incyte (Nasdaq:INCY) announced the U.S. Food and Drug Administration (FDA) ap...
Thursday, December 2, 2021
FDA Approves Exkivity (mobocertinib) for EGFR Exon20 Insertion+ Non-Small Cell Lung Cancer (NSCLC)
›
Takeda Pharmaceutical Company Limited announced the U.S. Food and Drug Administration (FDA) approval of Exkivity (mobocertinib) for...
Wednesday, December 1, 2021
FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine
›
Impel NeuroPharma, Inc. (NASDAQ: IMPL), announced the U.S. Food and Drug Administration (FDA) approval of Trudhesa ™ (dihydroergotamine...
Tuesday, November 30, 2021
Invega Hafyera (paliperidone palmitate) Extended-Release Injectable Suspension for schizophrenia
›
In continuation of my update on paliperidone palmitate The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Foo...
Monday, November 29, 2021
FDA Approves Welireg (belzutifan) for the Treatment of Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors
›
Merck (NYSE: MRK), announced that the U.S. Food and Drug Administration (FDA) has approved ' Welireg , an oral hypoxia-inducible facto...
1 comment:
Monday, November 15, 2021
FDA Approves Voxzogo (vosoritide) to Increase Linear Growth in Children with Achondroplasia
›
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced the U.S. Food and Drug Administration (FDA) approval of VOXZOGO™ (vosoritide) for...
FDA Approves Vuity (pilocarpine HCI ophthalmic solution) to Treat Presbyopia (Age-Related Blurry Near Vision)....
›
Allergan, an AbbVie (NYSE: ABBV) company, announced the U.S. Food and Drug Administration (FDA) approval of Vuity (pilocarpine HCl ophthal...
Tuesday, November 9, 2021
FDA Approves Seglentis (celecoxib and tramadol hydrochloride) for the Management of Acute Pain
›
In continuation of my update on celecoxib and tramadol The U.S. Food and Drug Administration (FDA) has approved Seglentis (celecoxib a...
FDA Approves Zimhi (naloxone hydrochloride) Injection for the Treatment of Opioid Overdose
›
In continuation of my update on naloxone hydrochloride , Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) announced the U.S. Food and ...
‹
›
Home
View web version